APA

Schwarer A. P., Butler J., Jackson K., Beligaswatte A., Martin L., Kennedy G., Daniela Z., Lewis I., Hiwase D., Wight J., He S., Grigg A., Morris K., Mollee P. & Marlton P. (2018). A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML. : HemaSphere.

Chicago

Schwarer Anthony P, Butler Jason, Jackson Kathryn, Beligaswatte Ashanka, Martin Louisa, Kennedy Glen, Daniela Zantomio, Lewis Ian, Hiwase Devendra, Wight Joel, He Simon, Grigg Andrew, Morris Kirk, Mollee Peter and Marlton Paula. 2018. A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML. : HemaSphere.

Harvard

Schwarer A. P., Butler J., Jackson K., Beligaswatte A., Martin L., Kennedy G., Daniela Z., Lewis I., Hiwase D., Wight J., He S., Grigg A., Morris K., Mollee P. and Marlton P. (2018). A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML. : HemaSphere.

MLA

Schwarer Anthony P, Butler Jason, Jackson Kathryn, Beligaswatte Ashanka, Martin Louisa, Kennedy Glen, Daniela Zantomio, Lewis Ian, Hiwase Devendra, Wight Joel, He Simon, Grigg Andrew, Morris Kirk, Mollee Peter and Marlton Paula. A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML. : HemaSphere. 2018.